CD44 and TGFβ1 synergise to induce expression of a functional NADPH oxidase in promyelocytic cells

Biochemical and Biophysical Research Communications

Volumn 343, Issue 2, 2006, Pages 609-616

  Basoni, Caroline ^a   Reuzeau, Edith ^a   Croft, Daniel ^a,b   Génot, Elisabeth ^a   Kramer, Ijsbrand M ^a  

^a INSTITUT EUROPÉEN DE CHIMIE ET BIOLOGIE   (France)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Differentiation; Haematopoiesis; Hyaluronan; Integrins; Monocytes; NADPH; Oxidase; TGF 1; U937

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; WESTERN BLOTTING; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GRANULOCYTE PRECURSOR; METABOLISM; MONOCYTE;

ANTIGENS, CD44; CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOCYTE PRECURSOR CELLS; HUMANS; MONOCYTES; NADPH OXIDASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33645127230     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.003     Document Type: Article

References (50)

1. P. Harris, and P. Ralph Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines J. Leukoc. Biol. 37 1985 407 422
2. C. Sundstrom, and K. Nilsson Establishment and characterization of a human histiocytic lymphoma cell line (U-937) Int. J. Cancer 17 1976 565 577
3. M. Lubbert, F. Herrmann, and H.P. Koeffler Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells Blood 77 1991 909 924
4. R.C. Dodd, M.S. Cohen, S.L. Newman, and T.K. Gray Vitamin D metabolites change the phenotype of monoblastic U937 cells Proc. Natl. Acad. Sci. USA 80 1983 7538 7541
5. K. Takeda, S. Iwamoto, H. Sugimoto, T. Takuma, N. Kawatani, M. Noda, A. Masaki, H. Morise, H. Arimura, and K. Konno Identity of differentiation inducing factor and tumour necrosis factor Nature 323 1986 338 340
6. B. Perussia, E.T. Dayton, V. Fanning, P. Thiagarajan, J. Hoxie, and G. Trinchieri Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway J. Exp. Med. 158 1983 2058 2080
7. U. Testa, R. Masciulli, E. Tritarelli, R. Pustorino, G. Mariani, R. Martucci, T. Barberi, A. Camagna, M. Valtieri, and C. Peschle Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines J. Immunol. 150 1993 2418 2430
8. M. Nambu, M. Morita, H. Watanabe, Y. Uenoyama, K.M. Kim, M. Tanaka, Y. Iwai, H. Kimata, M. Mayumi, and H. Mikawa Regulation of Fc gamma receptor expression and phagocytosis of a human monoblast cell line U937. Participation of cAMP and protein kinase C in the effects of IFN-gamma and phorbol ester J. Immunol. 143 1989 4158 4165
9. R. Kamijo, K. Takeda, M. Nagumo, and K. Konno Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines J. Immunol. 144 1990 1311 1316
10. L.R. Ellingsworth, J.E. Brennan, K. Fok, D.M. Rosen, H. Bentz, K.A. Piez, and S.M. Seyedin Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells J. Biol. Chem. 261 1986 12362 12367
11. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, and D. Calvin Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
12. H. Goey, J.R. Keller, T. Back, D.L. Longo, F.W. Ruscetti, and R.H. Wiltrout Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1 J. Immunol. 143 1989 877 880
13. J.T. Gallagher, E. Spooncer, and T.M. Dexter Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures J. Cell Sci. 63 1983 155 171
14. A. Aruffo, I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed CD44 is the principal cell surface receptor for hyaluronate Cell 61 1990 1303 1313
15. M. Culty, K. Miyake, P.W. Kincade, E. Sikorski, E.C. Butcher, and C. Underhill The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins J. Cell Biol. 111 1990 2765 2774
16. K. Miyake, C.B. Underhill, J. Lesley, and P.W. Kincade Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition J. Exp. Med. 172 1990 69 75
17. D.V. Delfino, K.D. Patrene, A.B. DeLeo, R. DeLeo, R.B. Herberman, and S.S. Boggs Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow J. Immunol. 152 1994 5171 5179
18. K. Miyake, K.L. Medina, S. Hayashi, S. Ono, T. Hamaoka, and P.W. Kincade Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures J. Exp. Med. 171 1990 477 488
19. J. Moll, S. Khaldoyanidi, J.P. Sleeman, M. Achtnich, I. Preuss, H. Ponta, and P. Herrlich Two different functions for CD44 proteins in human myelopoiesis J. Clin. Invest. 102 1998 1024 1034
20. S. Khaldoyanidi, J. Moll, S. Karakhanova, P. Herrlich, and H. Ponta Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages Blood 94 1999 940 949
21. K. Morimoto, E. Robin, M.C. Le Bousse-Kerdiles, Y. Li, D. Clay, C. Jasmin, and F. Smadja-Joffe CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells Blood 83 1994 657 662
22. P.W. Noble, F.R. Lake, P.M. Henson, and D.W. Riches Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages J. Clin. Invest. 91 1993 2368 2377
23. R.S. Charrad, Z. Gadhoum, J. Qi, A. Glachant, M. Allouche, C. Jasmin, C. Chomienne, and F. Smadja-Joffe Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines Blood 99 2002 290 299
24. R.S. Charrad, Y. Li, B. Delpech, N. Balitrand, D. Clay, C. Jasmin, C. Chomienne, and F. Smadja-Joffe Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia Nat. Med. 5 1999 669 676
25. D.S. Webb, Y. Shimizu, G.A. Van Seventer, S. Shaw, and T.L. Gerrard LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release Science 249 1990 1295 1297
26. M.F. Gruber, D.S. Webb, and T.L. Gerrard Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta J. Immunol. 148 1992 1113 1118
27. A. Hildebrand, M. Romaris, L.M. Rasmussen, D. Heinegard, D.R. Twardzik, W.A. Border, and E. Ruoslahti Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta Biochem. J. 302 Pt 2 1994 527 534
28. E. Ruoslahti, and Y. Yamaguchi Proteoglycans as modulators of growth factor activities Cell 64 1991 867 869
29. Y. Tanaka, D.H. Adams, and S. Shaw Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes Immunol. Today 14 1993 111 115
30. L.Y. Bourguignon, P.A. Singleton, H. Zhu, and B. Zhou Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells J. Biol. Chem. 277 2002 39703 39712
31. T. Eichholtz, K. Jalink, I. Fahrenfort, and W.H. Moolenaar The bioactive phospholipid lysophosphatidic acid is released from activated platelets Biochem. J. 291 Pt 3 1993 677 680
32. D.J. Grainger, P.R. Kemp, J.C. Metcalfe, A.C. Liu, R.M. Lawn, N.R. Williams, A.A. Grace, P.M. Schofield, and A. Chauhan The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis Nat. Med. 1 1995 74 79
33. R.M. Lyons, J. Keski-Oja, and H.L. Moses Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium J. Cell Biol. 106 1988 1659 1665
34. D.L. McLeod, M.M. Shreeve, and A.A. Axelrad Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E Blood 44 1974 517 534
35. A.N. de Belder, and K.O. Wik Preparation and properties of fluorescein-labelled hyaluronate Carbohydr. Res. 44 1975 251 257
36. A.W. Segal, P.G. Heyworth, S. Cockcroft, and M.M. Barrowman Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein Nature 316 1985 547 549
37. I.M. Kramer, A.J. Verhoeven, R.L. van der Bend, R.S. Weening, and D. Roos Purified protein kinase C phosphorylates a 47-kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease J. Biol. Chem. 263 1988 2352 2357
38. F.B. Wientjes, J.J. Hsuan, N.F. Totty, and A.W. Segal p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains Biochem. J. 296 Pt 3 1993 557 561
39. R.L. van der Bend, J. Brunner, K. Jalink, E.J. van Corven, W.H. Moolenaar, and W.J. van Blitterswijk Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid EMBO J. 11 1992 2495 2501
40. J.J. Keyzer, B.G. Wolthers, F.A. Muskiet, H. Breukelman, H.F. Kauffman, and K. de Vries Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values Anal. Biochem. 139 1984 474 481
41. T. Nonaka, M. Mio, M. Doi, and K. Tasaka Histamine-induced differentiation of HL-60 cells. The role of cAMP and protein kinase A Biochem. Pharmacol. 44 1992 1115 1121
42. C. Piquet-Pellorce, E. Schneider, and M. Dy GM-CSF in association with IL-1 triggers day-8 CFU-S into cell cycle: role of histamine J. Cell. Physiol. 149 1991 18 23
43. A. Shiedlin, R. Bigelow, W. Christopher, S. Arbabi, L. Yang, R.V. Maier, N. Wainwright, A. Childs, and R.J. Miller Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord Biomacromolecules 5 2004 2122 2127
44. R. Yang, Z. Yan, F. Chen, G.K. Hansson, and R. Kiessling Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity Scand. J. Immunol. 55 2002 2 13
45. A. Abo, E. Pick, A. Hall, N. Totty, C.G. Teahan, and A.W. Segal Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 Nature 353 1991 668 670
46. M.A. Cassatella, L. Hartman, B. Perussia, and G. Trinchieri Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells J. Clin. Invest. 83 1989 1570 1579
47. A. Yayon, M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64 1991 841 848
48. S.M. Wahl, D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, A.B. Roberts, and M.B. Sporn Transforming growth factor type beta induces monocyte chemotaxis and growth factor production Proc. Natl. Acad. Sci. USA 84 1987 5788 5792
49. T.D. Camenisch, A.P. Spicer, T. Brehm-Gibson, J. Biesterfeldt, M.L. Augustine, A. Calabro Jr., S. Kubalak, S.E. Klewer, and J.A. McDonald Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme J. Clin. Invest. 106 2000 349 360
50. V. Ellenrieder, S.F. Hendler, W. Boeck, T. Seufferlein, A. Menke, C. Ruhland, G. Adler, and T.M. Gress Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation Cancer Res. 61 2001 4222 4228